Literature DB >> 33541421

Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation.

Xiaoqing Fan1, Haoran Yang2,3, Chenggang Zhao3, Lizhu Hu3, Delong Wang1, Ruiting Wang1, Zhiyou Fang2,3, Xueran Chen4,5.   

Abstract

BACKGROUND: A large number of preclinical studies have shown that local anesthetics have a direct inhibitory effect on tumor biological activities, including cell survival, proliferation, migration, and invasion. There are few studies on the role of local anesthetics in cancer stem cells. This study aimed to determine the possible role of local anesthetics in glioblastoma stem cell (GSC) self-renewal and the underlying molecular mechanisms.
METHODS: The effects of local anesthetics in GSCs were investigated through in vitro and in vivo assays (i.e., Cell Counting Kit 8, spheroidal formation assay, double immunofluorescence, western blot, and xenograft model). The acyl-biotin exchange method (ABE) assay was identified proteins that are S-acylated by zinc finger Asp-His-His-Cys-type palmitoyltransferase 15 (ZDHHC15). Western blot, co-immunoprecipitation, and liquid chromatograph mass spectrometer-mass spectrometry assays were used to explore the mechanisms of ZDHHC15 in effects of local anesthetics in GSCs.
RESULTS: In this study, we identified a novel mechanism through which local anesthetics can damage the malignant phenotype of glioma. We found that local anesthetics prilocaine, lidocaine, procaine, and ropivacaine can impair the survival and self-renewal of GSCs, especially the classic glioblastoma subtype. These findings suggest that local anesthetics may weaken ZDHHC15 transcripts and decrease GP130 palmitoylation levels and membrane localization, thus inhibiting the activation of IL-6/STAT3 signaling.
CONCLUSIONS: In conclusion, our work emphasizes that ZDHHC15 is a candidate therapeutic target, and local anesthetics are potential therapeutic options for glioblastoma.

Entities:  

Keywords:  GP130; Glioblastoma stem cells; Local anesthetics; STAT3; Self-renewal; ZDHHC15

Mesh:

Substances:

Year:  2021        PMID: 33541421      PMCID: PMC7863430          DOI: 10.1186/s13287-021-02175-2

Source DB:  PubMed          Journal:  Stem Cell Res Ther        ISSN: 1757-6512            Impact factor:   6.832


  60 in total

Review 1.  Cancer recurrence after surgery: direct and indirect effects of anesthetic agents.

Authors:  Aniket N Tavare; Nicholas J S Perry; Laura L Benzonana; Masao Takata; Daqing Ma
Journal:  Int J Cancer       Date:  2011-11-09       Impact factor: 7.396

Review 2.  The role of S-acylation in protein trafficking.

Authors:  Jose L Daniotti; Maria P Pedro; Javier Valdez Taubas
Journal:  Traffic       Date:  2017-09-24       Impact factor: 6.215

Review 3.  Activating mutations of the gp130/JAK/STAT pathway in human diseases.

Authors:  Juliane Lokau; Christoph Garbers
Journal:  Adv Protein Chem Struct Biol       Date:  2018-12-27       Impact factor: 3.507

Review 4.  Human DHHC proteins: a spotlight on the hidden player of palmitoylation.

Authors:  Justyna Korycka; Agnieszka Łach; Elżbieta Heger; Dżamila M Bogusławska; Marcin Wolny; Monika Toporkiewicz; Katarzyna Augoff; Jan Korzeniewski; Aleksander F Sikorski
Journal:  Eur J Cell Biol       Date:  2011-12-16       Impact factor: 4.492

Review 5.  gp130: a promising drug target for cancer therapy.

Authors:  Shili Xu; Nouri Neamati
Journal:  Expert Opin Ther Targets       Date:  2013-10-07       Impact factor: 6.902

6.  Cocaine use may induce telomere shortening in individuals with HIV infection.

Authors:  Shenghan Lai; Christopher M Heaphy; Anthony J Rizzo; David D Celentano; Gary Gerstenblith; Ji Li; Richard D Moore; Glenn Treisman; Shaoguang Chen; Parker Foster; Thomas Kickler; Hong Lai
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-02-02       Impact factor: 5.067

Review 7.  Regional anaesthesia and cancer metastases: the implication of local anaesthetics.

Authors:  E G Votta-Velis; T Piegeler; R D Minshall; J Aguirre; B Beck-Schimmer; D E Schwartz; A Borgeat
Journal:  Acta Anaesthesiol Scand       Date:  2013-11       Impact factor: 2.105

8.  Rif1 S-acylation mediates DNA double-strand break repair at the inner nuclear membrane.

Authors:  Gabriele A Fontana; Daniel Hess; Julia K Reinert; Stefano Mattarocci; Benoît Falquet; Dominique Klein; David Shore; Nicolas H Thomä; Ulrich Rass
Journal:  Nat Commun       Date:  2019-06-10       Impact factor: 14.919

9.  DHHC protein family targets different subsets of glioma stem cells in specific niches.

Authors:  Xueran Chen; Lei Hu; Haoran Yang; Huihui Ma; Kaiqin Ye; Chenggang Zhao; Zhiyang Zhao; Haiming Dai; Hongzhi Wang; Zhiyou Fang
Journal:  J Exp Clin Cancer Res       Date:  2019-01-18
View more
  5 in total

1.  Palmitoyl transferases act as potential regulators of tumor-infiltrating immune cells and glioma progression.

Authors:  Feng Tang; Chao Yang; Feng-Ping Li; Dong-Hu Yu; Zhi-Yong Pan; Ze-Fen Wang; Zhi-Qiang Li
Journal:  Mol Ther Nucleic Acids       Date:  2022-05-04       Impact factor: 10.183

2.  LINC02308 promotes the progression of glioma through activating mTOR/AKT-signaling pathway by targeting miR-30e-3p/TM4SF1 axis.

Authors:  Xianfeng Gao; Xiaoya Wang; Huaiqiang He; Yang Cao
Journal:  Cell Biol Toxicol       Date:  2021-05-04       Impact factor: 6.691

3.  Ropivacaine represses the proliferation, invasion, and migration of glioblastoma via modulating the microRNA-21-5p/KAT8 regulatory NSL complex subunit 2 axis.

Authors:  Zexiang Deng; Yanping Jian; Hongwei Cai
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

4.  Hypomethylation-induced prognostic marker zinc finger DHHC-type palmitoyltransferase 12 contributes to glioblastoma progression.

Authors:  Feng Lu; Shang-Hang Shen; Shizhong Wu; Pengfeng Zheng; Kun Lin; Jingwei Liao; Xiaohang Jiang; Guangming Zeng
Journal:  Ann Transl Med       Date:  2022-03

Review 5.  Procaine-The Controversial Geroprotector Candidate: New Insights Regarding Its Molecular and Cellular Effects.

Authors:  Daniela Gradinaru; Anca Ungurianu; Denisa Margina; Maria Moreno-Villanueva; Alexander Bürkle
Journal:  Oxid Med Cell Longev       Date:  2021-07-31       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.